Valid cardiac biomarkers. Part I

Biomarkers are widely used for the diagnosing of diseases, evaluation of their severity, prediction of outcomes, and for monitoring the effectiveness and safety of targeted therapy. This review describes specific cardiac biomarkers approved by FDA (Food and Drug AdministrationбUSA). The list of desc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Kardiovaskuli͡a︡rnai͡a︡ terapii͡a︡ i profilaktika 2020-09, Vol.19 (4), p.2573
Hauptverfasser:	Metelskaya, V. A., Gumanova, N. G.
Format:	Artikel
Sprache:	eng
Schlagworte:	atherosclerosis cardiovascular diseases circulating biomarkers coronary artery disease fda laboratory diagnostics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Biomarkers are widely used for the diagnosing of diseases, evaluation of their severity, prediction of outcomes, and for monitoring the effectiveness and safety of targeted therapy. This review describes specific cardiac biomarkers approved by FDA (Food and Drug AdministrationбUSA). The list of described biomarkers is not exhaustive. In addition to the general concepts of biomarkers, definitions and classification, this Part I of the review contains data on diagnostic and prognostic biomarkers of cardiovascular diseases associated with atherosclerosis.
ISSN:	1728-8800 2619-0125
DOI:	10.15829/1728-8800-2020-2573